# 2025-04029: Drug Importer Debarred 5 Years Over Unapproved Goods.

2025-04029, Alnashir Alibhai Punjani: Final Debarment Order, is a Federal Register notice from Health and Human Services Department, Food and Drug Administration published 2025-03-13, effective 2025-03-13; PRIA reads it as touching household money (as of 2026-09-30).

- Canonical: https://policyrisk.com/federal-register/2025-04029
- As of: 2026-09-30
- Plain-text twin of the page above; the HTML and this file carry the same facts.

## Facts
- Document number: 2025-04029
- Title: Alnashir Alibhai Punjani: Final Debarment Order
- Type: Notice
- Agencies: Health and Human Services Department; Food and Drug Administration
- Citation: 90 FR 11990
- Published: 2025-03-13
- Effective: 2025-03-13
- Comments close: not stated
- Significant: no
- Touches household money: yes
- Regulation identifier numbers: none
- Last updated: 2026-09-30

## In one line

Drug Importer Debarred 5 Years Over Unapproved Goods.

## Summary

Alnashir Alibhai Punjani is banned for 5 years from importing any drugs into the U.S. because he was convicted of a serious crime involving unapproved drugs. He didn’t respond to the FDA’s notice, so the ban starts on March 13, 2025. Punjani can apply to end the ban anytime, but must follow strict rules to keep personal info private.

## Abstract

The Food and Drug Administration (FDA or the Agency) is issuing an order under the Federal Food, Drug, and Cosmetic Act (FD&C Act) debarring Alnashir Alibhai Punjani for a period of 5 years from importing or offering for import any drug into the United States. FDA bases this order on a finding that Mr. Punjani was convicted of one felony count under Federal law for conspiracy to deliver and introduce unapproved drugs. The factual basis supporting Mr. Punjani's conviction, as described below, is conduct relating to the importation into the United States of a drug or controlled substance. Mr. Punjani was given notice of the proposed debarment and was given an opportunity to request a hearing to show why he should not be debarred. As of November 10, 2024 (30 days after receipt of the notice), Mr. Punjani had not responded. Mr. Punjani's failure to respond and request a hearing constitutes a waiver of his right to a hearing concerning this matter.

## Effects PRIA read

- 5‑Year Ban on Importing Drugs: cost, high. Alnashir Alibhai Punjani is debarred for 5 years from importing or offering for import any drug into the United States, effective March 13, 2025. The debarment follows his June 18, 2024 conviction for conspiracy to deliver and introduce unapproved drugs and was imposed under the Federal Food, Drug,…
- Helping Him Import Is Prohibited: cost, low. As of March 13, 2025, importing or offering for import any drug by, with the assistance of, or at the direction of Mr. Punjani is a prohibited act under section 301(cc) of the FD&C Act. Businesses or individuals that would assist him in importing drugs would be engaging in a prohibited act.
- How to Apply to End Debarment; Privacy Rules: mixed, medium. Mr. Punjani may apply at any time to terminate the debarment by submitting an application to docket FDA-2024-N-3314. Electronic applications submitted to https://www.regulations.gov (including attachments) will be posted publicly unchanged, so confidential information should not be included there;…

## Related documents

- [2026-20848](https://policyrisk.com/federal-register/2026-20848): Use of Salt Substitutes To Reduce the Sodium Content in Standardized Foods, 2026-10-13
- [2026-16296](https://policyrisk.com/federal-register/2026-16296): Substances Generally Recognized as Safe, 2026-08-11
- [2026-14073](https://policyrisk.com/federal-register/2026-14073): Drug Establishment Registration and Drug Listing Requirements for Establishments Engaged in Distributed Manufacturing and Certain Foreign E…, 2026-07-13
- [2026-13047](https://policyrisk.com/federal-register/2026-13047): Establishment Registration and Product Listing for Tobacco Products, 2026-06-29
- [2025-04978](https://policyrisk.com/federal-register/2025-04978): Nonprescription Drug Product With an Additional Condition for Nonprescription Use, 2025-03-25
- [2025-01840](https://policyrisk.com/federal-register/2025-01840): Nonprescription Drug Product With an Additional Condition for Nonprescription Use, 2025-01-27

## Sources
- [2025-04029 on federalregister.gov](https://www.federalregister.gov/documents/2025/03/13/2025-04029/alnashir-alibhai-punjani-final-debarment-order)
- [2025-04029 as published (PDF)](https://www.govinfo.gov/content/pkg/FR-2025-03-13/pdf/2025-04029.pdf)

## Related
- [Previous: 2025-04028, Harpreet Singh: Final Debarment Order](https://policyrisk.com/federal-register/2025-04028)
- [Next: 2025-04030, Jonathan Corbett Cosie: Final Debarment Order](https://policyrisk.com/federal-register/2025-04030)
- [All Federal Register documents](https://policyrisk.com/federal-register)

Source: PRIA, https://policyrisk.com/federal-register/2025-04029 (as of 2026-09-30).
